Blue Sage Capital has successfully exited its investment in Controlled Recovery, selling the company to R360 Treatment, which enhances CRI's growth prospects in the non-hazardous oil and gas waste management sector.

Information on the Target

Controlled Recovery, commonly referred to as CRI, is recognized as the largest facility for non-hazardous oil and gas waste management in the United States. Under the management of John Barnidge, who serves as CEO, CRI has continually expanded its capabilities and operations to meet the growing demand in this critical sector. The facility plays a pivotal role in ensuring the safe and efficient disposal and management of waste, aligning with industry standards and environmental regulations.

Blue Sage Capital has successfully exited its investment in CRI, having been the majority controlling shareholder during its tenure. This strategic decision to sell the company to R360 Treatment signals not just a profitable return for Blue Sage but also a promising future for CRI as it embarks on further growth initiatives.

Industry Overview in the Target’s Specific Country

The oil and gas waste management industry in the United States has seen significant growth, driven by increasing regulatory pressures and a focus on environmentally responsible practices. As companies within

View Source

Similar Deals

Baker Hughes Company Chart Industries Inc.

2025

Buyout Oil & Gas Storage United States of America
LS Power BP Wind Energy North America Inc.

2025

Buyout Wind Systems & Equipment United States of America
Iron Oak Energy Solutions LLC High Roller Sand

2025

Buyout Oil Exploration & Production - Onshore United States of America
EOG Resources, Inc. Encino Acquisition Partners

2025

Buyout Oil Exploration & Production - Onshore United States of America
Epic Star Energy Pacific Current

2025

Buyout Photovoltaic Solar Systems & Equipment United States of America
Brookfield Infrastructure Partners L.P. Colonial Enterprises

2025

Buyout Petroleum Product Wholesale United States of America

R360 Treatment

invested in

Controlled Recovery (CRI)

in 2023

in a Buyout deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert